INFIQ

INFINITY PHARMS INC by Infinity Pharmaceuticals, Inc. (INFIQ)

About INFINITY PHARMS INC by Infinity Pharmaceuticals, Inc. (INFIQ)

Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. It focuses on its drug development segment. The company was founded by Steven H. Holtzman and Matthew D. Shair on March 22, 1995 and is headquartered in Cambridge, MA.

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
1,884
P/E ratio
--

INFINITY PHARMS INC by Infinity Pharmaceuticals, Inc. News

Details

Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.00
52 Week Low
$0.00
Market cap
100
Dividend yield
0.00%
Volume
--
Avg. volume
1,884
P/E ratio
--